[1]黎 冉.阿托伐他汀钙干预对冠心病患者围术期心脏事件的影响[J].福建医药杂志,2020,42(01):26-28.
　LI Ran..Effect of atorvastatin calcium on perioperative cardiac events in patients with coronary heart disease[J].FUJIAN MEDICAL JOURNAL,2020,42(01):26-28.
点击复制

阿托伐他汀钙干预对冠心病患者围术期心脏事件的影响()
分享到：

《福建医药杂志》[ISSN:1002-2600/CN:35-1071/R]

卷:
42
期数:
2020年01期
页码:
26-28
栏目:
临床研究
出版日期:
2020-03-30

文章信息/Info

Title:
Effect of atorvastatin calcium on perioperative cardiac events in patients with coronary heart disease
文章编号:
1002-2600(2020)01-0026-03
作者:
黎 冉
福建医科大学第二临床医学院 福建医科大学附属第二医院(泉州 362000)
Author(s):
LI Ran.
The Second Affiliated Hospital of Fujian Medical University, The Second Clinical Medical College of Fujian Medical University,Quanzhou,Fujian 362000, China
关键词:
冠心病;  心脏事件;  高敏C反应蛋白;  阿托伐他汀钙
Keywords:
coronary heart disease;  heart event;  high sensitive C-reactive protein;  atorvastatin calcium
分类号:
R541.4
文献标志码:
B
摘要:
目的 探讨阿托伐他汀钙术前干预对冠心病患者围术期发生心脏事件的影响。方法 收集本院住院确诊为冠心病的非心脏手术患者120例(已服用阿托伐他汀钙20 mg/d)。根据临床特点随机分为经过增加阿托伐他汀钙调控的观察组40 mg/d和阿托伐他汀钙20 mg/d调控的对照组。比较两组高敏C反应蛋白水平、肌酸激酶水平及患者围术期心脏事件发生的情况。结果 观察组高敏C反应蛋白平均水平为(4.88±2.19)mg/L,对照组为(7.95±2.21)mg/L,两组比较的差异有统计学意义(P<0.05); 干预后观察组肌酸激酶水平为(15.99±146.7)U/L,对照组为(127.4±66.0)U/L; 术后并发症发生比较的差异有统计学意义(P<0.05)。结论 术前40 mg剂量阿托伐他汀钙干预可减少冠心病患者围术期心脏事件的发生。
Abstract:
Objective To explore the effect of preoperative intervention of atorvastatin calcium on perioperative cardiac events in patients with coronary heart disease.Methods A total of 120 patients(20 mg/d of atorvastatin calcium)with coronary heart disease were collected.According to the clinical characteristics, the patients were randomly divided into two groups: observation group(40 mg/d)and control group(20 mg/d).The level of high-sensitivity C-reactive protein, the level of creatine kinase and the occurrence of perioperative cardiac events were compared between the two groups.Results The average level of high sensitive C-reactive protein was(4.88±2.19)mg/L in the observation group and(7.95±2.21)mg/L in the control group, the difference between the two groups was statistically significant(P<0.05),Creatine kinase level in the observation group was(159.9±146.7)U/L,while it was(127.4±66.0)U/L in control group. and the difference between the postoperative complications was statistically significant(P<0.05).Conclusion The intervention of 40 mg of atorvastatin calcium before operation can reduce the occurrence of perioperative cardiac events in patients with coronary heart disease.

参考文献/References:

[1] Schnabil R B,Larson M G,Yamamoto J F,et al.Relation of multiple inflammatory biomarkers to incident atrial fibrillation[J]. Am J Cardiol,2009,104(1):92.
[2] 曲歌,许力,于春华.术前超敏C反应蛋白和B型脑钠肽前体水平在老年冠心病患者围术期心脏事件中的预测价值[J].中国老年学杂志,2016,36(12):2898-2900.
[3] Rifai N, Ridker P M.High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease[J]. 2001, 47(3):403-11.
[4] 陆峰, 周春刚, 朱明, 等.超敏C反应蛋白和冠状动脉造影术确定的冠心病冠脉病变严重程度相关性的直线回归分析[J]. 实用临床医药杂志, 2012,16(17):25.
[5] 王小燕.超敏C反应蛋白与冠状动脉病变严重程度的相关性分析[J]. 医学动物防制, 2012,28(6):119-121.
[6] 高阅春,李全,何继强,等.超敏C反应蛋白水平与冠心病严重程度及预后的相关性研究[J]. 中国全科医学, 2012,15(8):840-843.
[7] 曲歌, 许力, 于春华,等.术前血清超敏C反应蛋白对冠心病患者非心脏手术围术期心脏事件的预测作用[J]. 基础医学与临床, 2012, 32(12):1406-1410.
[8] 刘子嘉,许力,于春华,等.高龄冠心病患者行非心脏手术的围术期心脏事件危险因素分析[J].中国医学科学院学报,2015,37(5):541-548.
[9] Nicholls S J,Borgman M,Nissen S E, et al.Impact of statins on progression of atherosclerosis: rationale and design of SATURN(Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN)[J].Curr Med Res Opin, 2011, 27(6): 1119-1129.
[10] Sun Y, Qi G, Gao Y, et al.Effect of different loading doses of atorvastatin on percutaneous coronary intervention for acute coronary syndromes[J]. The Canadian journal of cardiology, 2010, 26(9):481-485.

相似文献/References:

[1]张健春 王新康.冠心病心律失常患者55例动态心电图与常规心电图对比分析[J].福建医药杂志,2018,40(06):68.
[2]孙伏清,周密,周晓兰,等.前纤维蛋白-1浓度与冠心病患者PCI术后2年患者发生主要不良心血管事件的关系[J].福建医药杂志,2022,44(04):17.
　SUN Fuqing,ZHOU Mi,ZHOU Xiaolan,et al.Association between baseline serum profilin-1 concentration and major adverse cardiovascular events in 2-year patients after percutaneous coronary intervention[J].FUJIAN MEDICAL JOURNAL,2022,44(01):17.

备注/Memo

备注/Memo:
基金项目:福建省中青年教师教育科研项目(JAT170247); 福建医科大学校苗圃科研基金项目(2015MP033)
更新日期/Last Update: 2020-03-30